Drug Type Recombinant protein |
Synonyms TAB014 monoclonal antibody injection, TAB 014, TAB-014 + [1] |
Target |
Action inhibitors |
Mechanism VEGF inhibitors(Vascular endothelial growth factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet age-related macular degeneration | Phase 3 | United States | 12 May 2022 | |
Glycogen Storage Disease Type II | Phase 1 | China | 15 Jun 2018 |
NCT05461339 (NEWS) Manual | Phase 3 | 488 | xcvvniuotn(hljtgmnwxf) = 成功达到主要研究终点 hxraiebplv (ckoaorizfd ) Met | Non-inferior | 02 Jan 2025 | ||